These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25967573)

  • 1. Time-Dependent Thrombus Resolution After Tissue-Type Plasminogen Activator in Patients With Stroke and Mice.
    Kim YD; Nam HS; Kim SH; Kim EY; Song D; Kwon I; Yang SH; Lee K; Yoo J; Lee HS; Heo JH
    Stroke; 2015 Jul; 46(7):1877-82. PubMed ID: 25967573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.
    Santos EM; Dankbaar JW; Treurniet KM; Horsch AD; Roos YB; Kappelle LJ; Niessen WJ; Majoie CB; Velthuis B; Marquering HA;
    Stroke; 2016 Aug; 47(8):2058-65. PubMed ID: 27338928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis in Real Time: Demonstration of Revascularization with Intravenous Thrombolysis Therapy in the CT Scanner.
    Tan J; Aysenne A; Singh V
    J Neuroimaging; 2017 Jan; 27(1):50-58. PubMed ID: 27653945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of thrombus resolution after intravenous thrombolysis assessed by CT-based thrombus imaging.
    Nam HS; Kim EY; Kim SH; Kim YD; Kim J; Lee HS; Nam CM; Heo JH
    Thromb Haemost; 2012 Apr; 107(4):786-94. PubMed ID: 22318312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus Volume as a Predictor of Nonrecanalization After Intravenous Thrombolysis in Acute Stroke.
    Yoo J; Baek JH; Park H; Song D; Kim K; Hwang IG; Kim YD; Kim SH; Lee HS; Ahn SH; Cho HJ; Kim GS; Kim J; Lee KY; Song TJ; Choi HY; Nam HS; Heo JH
    Stroke; 2018 Sep; 49(9):2108-2115. PubMed ID: 30354986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration.
    Kimura K; Sakamoto Y; Aoki J; Iguchi Y; Shibazaki K; Inoue T
    Stroke; 2011 Nov; 42(11):3150-5. PubMed ID: 21868738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke.
    Muchada M; Rodriguez-Luna D; Pagola J; Flores A; Sanjuan E; Meler P; Boned S; Alvarez-Sabin J; Ribo M; Molina CA; Rubiera M
    Stroke; 2014 Sep; 45(9):2734-8. PubMed ID: 25104845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.
    Alvarez-Sabín J; Molina CA; Ribó M; Arenillas JF; Montaner J; Huertas R; Santamarina E; Rubiera M
    Stroke; 2004 Nov; 35(11):2493-8. PubMed ID: 15472110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
    Lansberg MG; Thijs VN; Bammer R; Kemp S; Wijman CA; Marks MP; Albers GW;
    Stroke; 2007 Aug; 38(8):2275-8. PubMed ID: 17569874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Plasminogen Activator Use in Children: Bleeding Complications and Thrombus Resolution.
    Ansah DA; Patel KN; Montegna L; Nicholson GT; Ehrlich AC; Petit CJ
    J Pediatr; 2016 Apr; 171():67-72.e1-2. PubMed ID: 26707578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke.
    Delgado-Mederos R; Rovira A; Alvarez-Sabín J; Ribó M; Munuera J; Rubiera M; Santamarina E; Maisterra O; Delgado P; Montaner J; Molina CA
    Stroke; 2007 Mar; 38(3):955-60. PubMed ID: 17290028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.